DrugPatentWatch Database Preview» See Plans and Pricing
« Back to Dashboard
Bacitracinis the generic ingredient in twenty-one branded drugs marketed by X Gen Pharms, Akorn, Fresenius Kabi Usa, Mylan Asi, Pfizer, Pharmacia And Upjohn, Xellia Pharms Aps, Lilly, Perrigo Co Tennessee, Pharmaderm, Pharmafair, Combe, Naska, Apothekernes, Paddock Llc, Casper Pharma Llc, Bausch And Lomb, Monarch Pharms, Dow Pharm, Glaxosmithkline, and Altana, and is included in forty-four NDAs. Additional information is available in the individual branded drug profile pages.
There are twenty-seven drug master file entries for bacitracin. Seven suppliers are listed for this compound.
Recent Clinical Trials for bacitracin
Identify potential brand extensions & 505(b)(2) entrants
|Cairo University||Early Phase 1|
|Ascension South East Michigan||Phase 4|
|The University of Texas Health Science Center, Houston||Phase 4|
Pharmacology for bacitracin
|Physiological Effect||Decreased Cell Wall Synthesis & Repair |
Medical Subject Heading (MeSH) Categories for bacitracin
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Combe||BACITRACIN||bacitracin||OINTMENT;TOPICAL||062799-001||May 14, 1987||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Mylan Asi||BACITRACIN||bacitracin||INJECTABLE;INJECTION||090211-001||May 11, 2010||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Pharmacia And Upjohn||BACITRACIN||bacitracin||INJECTABLE;INJECTION||060733-002||Approved Prior to Jan 1, 1982||AP||RX||No||Yes||Start Trial||Start Trial||Start Trial|
|Naska||BACITRACIN||bacitracin||OINTMENT;TOPICAL||062857-001||Nov 13, 1987||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Perrigo Co Tennessee||NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC||bacitracin zinc; neomycin sulfate; polymyxin b sulfate||OINTMENT;OPHTHALMIC||060764-002||Approved Prior to Jan 1, 1982||AT||RX||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.